![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | C07D 307/20 | (2006.01) |
A61K 31/34 | (2006.01) | ||
A61K 31/66 | (2006.01) | ||
A61K 31/665 | (2006.01) | ||
A61K 31/70 | (2006.01) | ||
A61K 31/16 | (2006.01) | ||
C07D 405/12 | (2006.01) | ||
C07C 311/18 | (2006.01) | ||
C07H 15/18 | (2006.01) | ||
C07F 9/655 | (2006.01) | ||
C07F 9/6584 | (2006.01) |
(11) | Number of the document | 0933372 |
(13) | Kind of document | T |
(96) | European patent application number | 98104292.2 |
Date of filing the European patent application | 1998-03-10 | |
(97) | Date of publication of the European application | 1999-08-04 |
(45) | Date of publication and mention of the grant of the patent | 2007-12-26 |
(46) | Date of publication of the claims translation | 2008-04-25 |
(30) | Number | Date | Country code |
998050 | 1997-12-24 | US |
(72) |
Tung, Robert D., US
Hale, Michael R., US
Baker, Christopher T., US
Furfine, Eric Steven, US
Kaldor, Istvan, US
Kazmierski, Wieslaw Mieczyslaw, US
Spaltenstein, Andrew, US
|
(73) |
VERTEX PHARMACEUTICALS INCORPORATED,
130 Waverly Street, Cambridge, MA 02139-4242,
US
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Sulfonamido dariniai kaip aspartilproteazės inhibitorių provaistai |
Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
Payment date | Validity (years) | Amount | |
2017-02-20 | 20 | 347.00 EUR |